MMP9: a tough target for targeted therapy for cancer

K Augoff, A Hryniewicz-Jankowska, R Tabola, K Stach - Cancers, 2022 - mdpi.com
Simple Summary MMP9, due to its proteolytic activity, plays a key role in tumorigenesis by
regulating migration, epithelial-to-mesenchymal transition and survival of cancer cells …

Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?

DC Ziogas, C Theocharopoulos, T Koutouratsas… - Cancer Treatment …, 2023 - Elsevier
Marching into the second decade after the approval of ipilimumab, it is clear that immune
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …

[HTML][HTML] Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1

CH Lee, JH Bae, EJ Choe, JM Park, SS Park… - Theranostics, 2022 - ncbi.nlm.nih.gov
Extracellular vesicles (EVs) carrying tumor cell-derived programmed death-ligand 1 (PD-L1)
interact with programmed death 1 (PD-1)-producing T cells, thus significantly lowering a …

YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell …

Z Yang, G Yan, L Zheng, W Gu, F Liu, W Chen… - …, 2021 - Taylor & Francis
Metastasis and immune suppression account for the poor prognosis of oral squamous cell
carcinoma (OSCC). YKT6 is a member of the soluble NSF attachment protein receptor …

The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer

L He, Q Kang, KI Chan, Y Zhang, Z Zhong… - Frontiers in …, 2023 - frontiersin.org
Matrix metalloproteinases (MMPs) are an important class of enzymes in the body that
function through the extracellular matrix (ECM). They are involved in diverse …

Key matrix remodeling enzymes: functions and targeting in cancer

Z Piperigkou, K Kyriakopoulou, C Koutsakis… - Cancers, 2021 - mdpi.com
Simple Summary Proteolytic enzymes, such as matrix metalloproteinases, plasminogen
activators and cathepsins, as well as non-proteolytic enzymatic partners, such as …

[HTML][HTML] Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma

L Yang, YT He, S Dong, XW Wei, ZH Chen… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Methods We used single-cell transcriptome sequencing and multiplex
immunohistochemistry to investigate the immune microenvironment of EGFR-mutant and …

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy

Y Gu, Z Zhang, P Ten Dijke - Cellular & Molecular Immunology, 2023 - nature.com
Immune checkpoint blockade (ICB) therapy is a powerful option for cancer treatment.
Despite demonstrable progress, most patients fail to respond or achieve durable responses …

[HTML][HTML] Profiling of immune features to predict immunotherapy efficacy

Y Ye, Y Zhang, N Yang, Q Gao, X Ding, X Kuang… - The Innovation, 2022 - cell.com
Immune checkpoint blockade (ICB) therapies exhibit substantial clinical benefit in different
cancers, but relatively low response rates in the majority of patients highlight the need to …

The imbalance of MMP-2/TIMP-2 and MMP-9/TIMP-1 contributes to collagen deposition disorder in diabetic non-injured skin

P Zhou, C Yang, S Zhang, ZX Ke, DX Chen… - Frontiers in …, 2021 - frontiersin.org
The importance of the early diagnosis and treatment of diabetes and its cutaneous
complications has become increasingly recognized. When diabetic non-injured skin was …